|
Report Date : |
12.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
EUROSERUM S.R.O. |
|
|
|
|
Formerly Known As : |
Picarros, s.r.o. |
|
|
|
|
Registered Office : |
Revoluční 1489, 349 01 Stříbro |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
31.08.2000 |
|
|
|
|
Com. Reg. No.: |
C 14507 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
·
Engaged as producer of demineralized whey powder for infant food ·
Engaged in manufacturing and sale of milk
products, milk and whey. ·
Engaged in operation of dairies and cheese making subject product ranges includes: Whey powders · Sicalac® - Sicalac Premium (High Quality) · Sicalac 25 - 40 - 50 · Sicalac 70 - 90 · Sicalac Premium 50P - 80P Functional dairy
ingredients · SicaMilk®: · SicaCook®: · SicaChoc®: · SicaShine®: · SicaBake®: · Skimmed milk powder · Whole milk powder · Butter milk Powder · Whey permeate · Milk permeate Animal Feed · Sweet Whey · Sour Whey ·
Goat Whey |
|
|
|
|
No of Employees : |
47 (2014) |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Slow but Correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
The
|
Source : CIA |
EUROSERUM s.r.o.
Revoluční 1489
349 01 Stříbro
telephone: 00420/ 374 616 211
telefax: 00420/ 374 616 217
e-mail: pmarchal@euroserum.com
Web: www.euroserum.com
|
Company
development |
Constant
business development |
|
|
Order situation |
Good course of
business |
|
|
Terms of payment |
mostly within
agreed terms, but partly also delayed |
|
|
Business
connection |
Business connections
are not denied |
|
|
Legal form |
Private limited company |
|
|
Foundation |
31/08/2000 - Private limited company |
|
Comp. Register |
31/08/2000, Městský soud v
Praze, RegNr.: C 78944 |
|
Share Capital |
31/08/2000 |
CZK |
100 000,- |
|
|
|
21/05/2003 |
CZK |
15 680 000,- |
|
|
Shareholders |
|
CZK |
15 680 000,- |
|
|
|
Management |
Claude Gaudillat (19.04.1961) |
||||
|
|
Jean-Didier
Haegi (23.08.1960) |
|
|
Yves Rambaux (24.01.1954) |
|
General Data |
Manufacture and sale of milk products,
milk and whey. |
||
|
|
Main activity: producer of demineralized whey powder for
infant food Operation of dairies and cheese making |
|
|
|
|
Product details Whey powders · Sicalac® - Sicalac Premium (High Quality) · Sicalac 25 - 40 - 50 · Sicalac 70 - 90 · Sicalac Premium 50P - 80P Functional dairy
ingredients · SicaMilk®: · SicaCook®: · SicaChoc®: · SicaShine®: · SicaBake®: · Skimmed milk powder · Whole milk powder · Butter milk Powder · Whey permeate · Milk permeate Animal Feed · Sweet Whey · Sour Whey ·
Goat
Whey |
|
|
|
|
Former name(s) |
|
|
Trade name(s) |
|
|
Export: |
88% |
|
|
|
General
contacts: |
||
|
|
Address: |
|
|
Na Poříčí 25, 110 00 Praha
1 |
|
Staff |
2006 |
42 employees |
|
|
2007 |
45 employees |
|
|
2008 |
50 employees |
|
|
2009 |
52 employees |
|
|
2010 |
50 employees |
|
|
2011 |
50 employees |
|
|
2012 |
47 employees |
|
|
2013 |
47 employees |
|
|
2014 |
47 employees |
|||||
|
Annual Sales |
2005 |
actual sales |
CZK |
187 311 000,- |
|
||
|
|
2006 |
actual sales |
CZK |
216 247 000,- |
|
|
|
2007 |
actual sales |
CZK |
373 909 000,- |
|
|
|
2008 |
actual sales |
CZK |
214 855 000,- |
|
|
|
2009 |
actual sales |
CZK |
174 008 000,- |
|
|
|
2010 |
actual sales |
CZK |
286 710 000,- |
|
|
|
2011 |
actual sales |
CZK |
342 458 000,- |
|
|
|
2012 |
actual sales |
CZK |
447 682 000,- |
|
|
|
2013 |
actual sales |
CZK |
477 579 000,- |
|
|
|
The company is
not registered in the Central register of executions. |
|
Balance sheets |
The enclosed balance of 2013 from business
register, it is authenticated by the auditor. (31.12.2013 - 1 CZK) |
|
|
The enclosed profit/loss account of 2013
from business register, it is authenticated by the auditor. (31.12.2013 - 1
CZK) |
|
Remarks |
All the sources
of negative data accessible to public (insolvency registers, databases of
debtors of health insurance institutions, commercial bulletin, collection
database and others) are currently monitored. |
|
|
The company is a part of the European
group Euroserum, |
|
|
Bankers |
Sberbank CZ, a.s. |
|
|
Copyright: |
This information is addressed exclusively to the addressee. Contractor obligates to provide updated information. Although it is always put maximum effort to collect actual and exact information, it is not confirmed as delinquency if there are particular inaccurateness contained within the information, which are not considered as essential in terms of the objective for which the information is provided to the addressee. Contractor and recipient conform to the rules of the Name and Description Security Act, Nub.101/2000. According to the Name and Description Security Act, recipient has the right to process or to use forwarding data only for the purpose for which information has been sent to the recipient. Usage for other purpose is acceptable only in case referring to valid regulations of the above mentioned act. |
|
|
Balance |
31.12.2010 (CZK) |
31.12.2011 (CZK) |
31.12.2012 (CZK) |
31.12.2013 (CZK) |
|
r1 |
TOTAL ASSETS |
149 036 000 |
175 793 000 |
186 012 000 |
195 931 000 |
|
r2 |
Receivables for subscriptions |
0 |
0 |
0 |
0 |
|
r3 |
Fixed assets |
45 060 000 |
46 564 000 |
54 043 000 |
67 371 000 |
|
r4 |
Intangible fixed
assets |
947 000 |
589 000 |
832 000 |
0 |
|
r5 |
Incorporation expenses |
|
0 |
|
|
|
r6 |
Research and development |
|
0 |
|
|
|
r7 |
Software |
64 000 |
0 |
|
|
|
r8 |
Valuable rights |
|
0 |
|
|
|
r9 |
Goodwill |
|
0 |
|
|
|
r10 |
Other intangible fixed assets |
883 000 |
589 000 |
832 000 |
|
|
r11 |
Intangible fixed assets under construction |
|
0 |
|
|
|
r12 |
Advance payments for intangible fixed
assets |
|
0 |
|
|
|
r13 |
Tangible fixed
assets |
44 113 000 |
45 975 000 |
53 211 000 |
67 371 000 |
|
r14 |
Lands |
1 992 000 |
1 992 000 |
1 992 000 |
1 992 000 |
|
r15 |
Constructions |
24 704 000 |
26 102 000 |
25 511 000 |
29 087 000 |
|
r16 |
Equipment |
16 695 000 |
14 567 000 |
13 590 000 |
15 682 000 |
|
r17 |
Perennial corps |
|
0 |
|
|
|
r18 |
Breeding and draught animals |
|
0 |
|
|
|
r19 |
Other tangible fixed assets |
|
0 |
|
|
|
r20 |
Tangible fixed assets under construction |
722 000 |
3 314 000 |
12 118 000 |
20 610 000 |
|
r21 |
Advance payments for tangible fixed assets |
|
0 |
|
|
|
r22 |
Adjustment to acquired assets |
|
0 |
|
|
|
r23 |
Long-term
financial assets |
0 |
0 |
0 |
0 |
|
r24 |
Shares in controlled and managed
organizations |
|
0 |
|
|
|
r25 |
Shares in accounting units with
substantial influence |
|
0 |
|
|
|
r26 |
Other securities and shares |
|
0 |
|
|
|
r27 |
Loans to controlled and managed
organizations and to accounting unit with substantial influence |
|
0 |
|
|
|
r28 |
Other financial investments |
|
0 |
|
|
|
r29 |
Financial investments acquired |
|
0 |
|
|
|
r30 |
Advance payments for long-term financial
assets |
|
0 |
|
|
|
r31 |
Current assets |
103 963 000 |
129 221 000 |
131 969 000 |
128 552 000 |
|
r32 |
Inventory |
51 482 000 |
74 404 000 |
76 107 000 |
70 905 000 |
|
r33 |
Materials |
5 200 000 |
6 228 000 |
9 616 000 |
9 515 000 |
|
r34 |
Work in progress and semi-products |
|
0 |
|
|
|
r35 |
Finished products |
46 260 000 |
68 176 000 |
66 491 000 |
61 390 000 |
|
r36 |
Animals |
|
0 |
|
|
|
r37 |
Merchandise |
22 000 |
0 |
|
|
|
r38 |
Advance payments for inventory |
|
0 |
|
|
|
r39 |
Long-term
receivables |
0 |
0 |
0 |
0 |
|
r40 |
Trade receivables |
|
0 |
|
|
|
r41 |
Receivables from controlled and managed
organizations |
|
0 |
|
|
|
r42 |
Receivables from accounting units with
substantial influence |
|
0 |
|
|
|
r43 |
Receivables from partners, cooperative
members and association members |
|
0 |
|
|
|
r44 |
Long-term deposits given |
|
0 |
|
|
|
r45 |
Estimated receivable |
|
0 |
|
|
|
r46 |
Other receivables |
|
0 |
|
|
|
r47 |
Deferred tax receivable |
|
0 |
|
|
|
r48 |
Short-term
receivables |
48 444 000 |
49 560 000 |
54 014 000 |
54 117 000 |
|
r49 |
Trade receivables |
43 687 000 |
45 203 000 |
47 906 000 |
46 616 000 |
|
r50 |
Receivables from controlled and managed
organizations |
|
0 |
|
|
|
r51 |
Receivables from accounting units with
substantial influence |
|
0 |
|
|
|
r52 |
Receivables from partners, cooperative
members and association members |
|
0 |
|
|
|
r53 |
Receivables from social security and
health insurance |
|
0 |
|
|
|
r54 |
Due from state - tax receivable |
4 226 000 |
4 341 000 |
6 108 000 |
7 501 000 |
|
r55 |
Short-term deposits given |
531 000 |
16 000 |
|
|
|
r56 |
Estimated receivable |
|
0 |
|
|
|
r57 |
Other receivables |
|
0 |
|
|
|
r58 |
Short-term
financial assets |
4 037 000 |
5 257 000 |
1 848 000 |
3 530 000 |
|
r59 |
Cash |
72 000 |
72 000 |
124 000 |
66 000 |
|
r60 |
Bank accounts |
3 965 000 |
5 185 000 |
1 724 000 |
3 464 000 |
|
r61 |
Short-term securities and ownership
interests |
|
0 |
|
|
|
r62 |
Short-term financial assets acquired |
|
0 |
|
|
|
r63 |
Accruals |
13 000 |
8 000 |
0 |
8 000 |
|
r64 |
Deferred expenses |
13 000 |
8 000 |
|
8 000 |
|
r65 |
Complex deferred costs |
|
0 |
|
|
|
r66 |
Deferred income |
|
0 |
|
|
|
r67 |
TOTAL
LIABILITIES |
149 036 000 |
175 793 000 |
186 012 000 |
195 931 000 |
|
r68 |
Equity |
-45 551 000 |
-1 440 000 |
10 980 000 |
13 019 000 |
|
r69 |
Registered
capital |
15 680 000 |
15 680 000 |
15 680 000 |
15 680 000 |
|
r70 |
Registered capital |
15 680 000 |
15 680 000 |
15 680 000 |
15 680 000 |
|
r71 |
Company’s own shares and ownership
interests (-) |
|
0 |
|
|
|
r72 |
Changes of registered capital ( +/- ) |
|
0 |
|
|
|
r73 |
Capital funds |
0 |
4 481 000 |
0 |
0 |
|
r74 |
Share premium |
|
4 481 000 |
|
|
|
r75 |
Other capital funds |
|
0 |
|
|
|
r76 |
Differences from revaluation of assets and
liabilities ( +/- ) |
|
0 |
|
|
|
r77 |
Differences from revaluation in
transformation ( +/- ) |
|
0 |
|
|
|
r78 |
Reserve funds, statutory
reserve account for cooperatives, and other retained earnings |
4 481 000 |
0 |
4 481 000 |
4 481 000 |
|
r79 |
Legal reserve fund / indivisible fund |
4 481 000 |
0 |
4 481 000 |
4 481 000 |
|
r80 |
Statutory and other funds |
|
0 |
|
|
|
r81 |
Profit / loss -
previous years |
-47 058 000 |
-65 712 000 |
-21 601 000 |
-9 180 000 |
|
r82 |
Retained earnings from previous years |
|
0 |
|
|
|
r83 |
Accumulated losses from previous years |
-47 058 000 |
-65 712 000 |
-21 601 000 |
-9 180 000 |
|
r84 |
Profit / loss -
current year (+/-) |
-18 654 000 |
44 111 000 |
12 420 000 |
2 038 000 |
|
r85 |
Liabilities |
194 587 000 |
177 233 000 |
164 657 000 |
182 912 000 |
|
r86 |
Reserves |
0 |
6 315 000 |
603 000 |
1 272 000 |
|
r87 |
Reserves under special statutory
regulations |
|
0 |
|
|
|
r88 |
Reserves for pension and similar payables |
|
0 |
|
|
|
r89 |
Income tax reserves |
|
6 315 000 |
|
|
|
r90 |
Other reserves |
|
0 |
603 000 |
1 272 000 |
|
r91 |
Long-term payables |
0 |
0 |
0 |
0 |
|
r92 |
Trade payables |
|
0 |
|
|
|
r93 |
Payables to controlled and managed
organizations |
|
0 |
|
|
|
r94 |
Payables to accounting units with
substantial influence |
|
0 |
|
|
|
r95 |
Payables from partners, cooperative
members and association members |
|
0 |
|
|
|
r96 |
Long-term advances received |
|
0 |
|
|
|
r97 |
Issues bonds |
|
0 |
|
|
|
r98 |
Long-term notes payables |
|
0 |
|
|
|
r99 |
Estimated payables |
|
0 |
|
|
|
r100 |
Other payables |
|
0 |
|
|
|
r101 |
Deferred tax liability |
|
0 |
|
|
|
r102 |
Short-term
payables |
194 587 000 |
170 918 000 |
164 054 000 |
181 640 000 |
|
r103 |
Trade payables |
27 926 000 |
36 350 000 |
63 679 000 |
85 397 000 |
|
r104 |
Payables to controlled and managed
organizations |
159 455 000 |
121 767 000 |
85 377 000 |
84 469 000 |
|
r105 |
Payables to accounting units with
substantial influence |
|
0 |
|
|
|
r106 |
Payables from partners, cooperative members
and association members |
|
0 |
|
|
|
r107 |
Payroll |
1 108 000 |
865 000 |
843 000 |
884 000 |
|
r108 |
Payables to social securities and health
insurance |
671 000 |
523 000 |
487 000 |
545 000 |
|
r109 |
Due from state - tax liabilities and subsidies |
1 073 000 |
722 000 |
896 000 |
132 000 |
|
r110 |
Short-term deposits received |
|
0 |
|
|
|
r111 |
Issues bonds |
|
0 |
|
|
|
r112 |
Estimated payables |
4 309 000 |
10 668 000 |
12 751 000 |
10 183 000 |
|
r113 |
Other payables |
45 000 |
23 000 |
21 000 |
30 000 |
|
r114 |
Bank loans and
financial accommodations |
0 |
0 |
0 |
0 |
|
r115 |
Long-term bank loans |
0 |
0 |
0 |
0 |
|
r116 |
Short-term bank loans |
0 |
0 |
0 |
0 |
|
r117 |
Short-term accommodations |
0 |
0 |
0 |
0 |
|
r118 |
Accruals |
0 |
0 |
10 375 000 |
0 |
|
r119 |
Accrued expenses |
|
0 |
|
|
|
r120 |
Deferred revenues |
|
0 |
10 375 000 |
|
|
|
profit/loss
account |
31.12.2010 (CZK) |
31.12.2011 (CZK) |
31.12.2012 (CZK) |
31.12.2013 (CZK) |
|
|
a1 |
Turnover |
286 710 000 |
342 458 000 |
447 682 000 |
477 579 000 |
|
|
a2 |
Revenues from sold goods |
17 748 000 |
14 169 000 |
9 745 000 |
3 413 000 |
|
|
a3 |
Expenses on sold goods |
17 835 000 |
11 579 000 |
8 947 000 |
3 230 000 |
|
|
a4 |
|
-87 000 |
2 590 000 |
798 000 |
183 000 |
|
|
a5 |
Production |
345 380 000 |
389 888 000 |
475 513 000 |
464 574 000 |
|
|
a6 |
Revenues from own products and services |
268 962 000 |
328 289 000 |
437 937 000 |
474 166 000 |
|
|
a7 |
Change in inventory of own products |
30 077 000 |
23 866 000 |
-278 000 |
-9 592 000 |
|
|
a8 |
Capitalization |
46 341 000 |
37 733 000 |
37 854 000 |
|
|
|
a9 |
Production
consumption |
334 550 000 |
357 337 000 |
433 674 000 |
434 937 000 |
|
|
a10 |
Consumption of material and energy |
299 084 000 |
314 887 000 |
385 590 000 |
381 178 000 |
|
|
a11 |
Services |
35 466 000 |
42 450 000 |
48 084 000 |
53 759 000 |
|
|
a12 |
Added value |
10 743 000 |
35 141 000 |
42 637 000 |
29 820 000 |
|
|
a13 |
Personnel
expenses |
18 477 000 |
19 281 000 |
19 135 000 |
20 087 000 |
|
|
a14 |
Wages and salaries |
13 425 000 |
13 983 000 |
13 867 000 |
14 624 000 |
|
|
a15 |
Renumeration of board members |
|
0 |
|
|
|
|
a16 |
Social security expenses and health
insurance |
4 506 000 |
4 693 000 |
4 708 000 |
5 002 000 |
|
|
a17 |
Other social expenses |
546 000 |
605 000 |
560 000 |
461 000 |
|
|
a18 |
Taxes and fees |
355 000 |
347 000 |
377 000 |
454 000 |
|
|
a19 |
Depreciations of intangible and tangible
assets |
6 850 000 |
6 136 000 |
6 344 000 |
7 015 000 |
|
|
a20 |
Revenues from
disposals of fixed assets and materials |
283 000 |
493 000 |
117 000 |
62 000 |
|
|
a21 |
Revenues from disposals of fixed assets |
283 000 |
54 000 |
|
|
|
|
a22 |
Revenues from disposals of materials |
|
439 000 |
117 000 |
62 000 |
|
|
a23 |
Net book value
of disposed fixed assets and materials |
246 000 |
421 000 |
0 |
0 |
|
|
a24 |
Net book value of sold fixed assets |
246 000 |
54 000 |
|
|
|
|
a25 |
Net book value of sold material |
|
367 000 |
|
|
|
|
a26 |
Change in operating reserves and
adjustments and complex deferred costs ( + / - ) |
1 101 000 |
1 459 000 |
-2 576 000 |
-1 310 000 |
|
|
a27 |
Other operating revenues |
4 452 000 |
48 110 000 |
2 984 000 |
1 209 000 |
|
|
a28 |
Other operating expenses |
4 275 000 |
5 627 000 |
3 719 000 |
1 863 000 |
|
|
a29 |
Transfer of operating revenues |
|
0 |
|
|
|
|
a30 |
Transfer of operating expenses |
|
0 |
|
|
|
|
a31 |
Operating profit
/ loss |
-15 826 000 |
50 473 000 |
18 739 000 |
2 982 000 |
|
|
a32 |
Revenues from sales of securities and
ownership interests |
|
0 |
|
|
|
|
a33 |
Sold securities and ownership interests |
|
0 |
|
|
|
|
a34 |
Revenues from
long-term financial assets |
|
0 |
|
|
|
|
a35 |
Revenues from shares in controlled and managed
organizations and in accounting units with substantial influence |
|
0 |
|
|
|
|
a36 |
Revenues from others securities and
ownership interests |
|
0 |
|
|
|
|
a37 |
Revenues from other long-term financial
assets |
|
0 |
|
|
|
|
a38 |
Revenues from short-term financial assets |
|
0 |
|
|
|
|
a39 |
Expenses associated with financial assets |
|
0 |
|
|
|
|
a40 |
Revenues from revaluation of securities
and derivatives |
|
0 |
|
|
|
|
a41 |
Cost of revaluation of securities and derivatives |
|
0 |
|
|
|
|
a42 |
Change in financial reserves and
adjustments ( + / - ) |
|
0 |
|
|
|
|
a43 |
Interest revenues |
0 |
0 |
0 |
0 |
|
|
a44 |
Interest expenses |
2 213 000 |
2 129 000 |
1 464 000 |
892 000 |
|
|
a45 |
Other financial revenues |
-56 000 |
2 172 000 |
240 000 |
961 000 |
|
|
a46 |
Other financial expenses |
559 000 |
90 000 |
2 177 000 |
571 000 |
|
|
a47 |
Transfer of financial revenues |
|
0 |
|
|
|
|
a48 |
Transfer of financial expenses |
|
0 |
|
|
|
|
a49 |
Profit / loss
from financial operations ( transactions ) |
-2 828 000 |
-47 000 |
-3 401 000 |
-502 000 |
|
|
a50 |
Income tax on
ordinary income |
0 |
6 315 000 |
2 918 000 |
442 000 |
|
|
a51 |
Due tax |
|
6 315 000 |
2 918 000 |
442 000 |
|
|
a52 |
Tax deferred |
|
0 |
|
|
|
|
a53 |
Operating profit
/ loss ordinary activity |
-18 654 000 |
44 111 000 |
12 420 000 |
2 038 000 |
|
|
a54 |
Extraordinary revenues |
|
0 |
|
|
|
|
a55 |
Extraordinary expenses |
|
0 |
|
|
|
|
a56 |
Income tax on
extraordinary income |
|
0 |
|
|
|
|
a57 |
Due tax |
|
0 |
|
|
|
|
a58 |
Tax deferred |
|
0 |
|
|
|
|
a59 |
Operating profit
/ loss extraordinary activity |
0 |
0 |
0 |
0 |
|
|
a60 |
Transfer profit ( loss ) to partners (+/-) |
|
0 |
|
|
|
|
a61 |
Profit / loss of
current accounting period (+/-) |
-18 654 000 |
44 111 000 |
12 420 000 |
2 038 000 |
|
|
a62 |
Profit / loss
before tax (+/-) |
-18 654 000 |
50 426 000 |
15 338 000 |
2 480 000 |
|
|
|
Operating cash
flow |
-53 632 000 |
4 013 000 |
36 283 000 |
10 741 000 |
|
|
|
Investment cash
flow |
-1 564 000 |
-8 105 000 |
-3 302 000 |
-8 151 000 |
|
|
|
Financial cash
flow |
58 997 000 |
5 312 000 |
-36 390 000 |
908 000 |
|
|
|
Receivables
after due date total |
11 139 000 |
5 928 000 |
6 234 000 |
4 227 000 |
|
|
|
Liabilities
after due date total |
764 000 |
8 153 000 |
25 324 000 |
29 317 000 |
|
|
Balance indices |
|
31.12.2010 |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
Return on total assets ROA (in %) |
a62/r1 * 100 |
-12,52 |
28,68 |
8,25 |
1,27 |
|
|
Return on equity ROE (in %) |
a62/r68 * 100 |
40,95 |
-3 501,81 |
139,69 |
19,05 |
|
|
Return on sales ROS (in %) |
a62/a1 * 100 |
-6,51 |
14,72 |
3,43 |
0,52 |
|
|
Turnover of receivables (in days) |
r49/a1 * 365 |
55,62 |
48,18 |
39,06 |
35,63 |
|
|
Turnover of liabilities (in days) |
r103/a1 * 365 |
35,55 |
38,74 |
51,92 |
65,27 |
|
|
Turnover of inventories (days) |
r32/a1 * 365 |
65,54 |
79,30 |
62,05 |
54,19 |
|
|
Net working capital (in ths. CZK) |
r31 - r102 - r116 - r117 |
-90 624,00 |
-41 697,00 |
-32 085,00 |
-53 088,00 |
|
|
Ratio of accounts payable to accounts
receivable (in %) |
(r39+r48) / (r91+r102) * 100 |
24,90 |
29,00 |
32,92 |
29,79 |
|
|
Ratio of profit/loss to tangible assets
(in%) |
r3 / a1 * 100 |
15,72 |
13,60 |
12,07 |
14,11 |
|
|
Current ratio |
r31 / (r102+r116+r117) |
0,53 |
0,76 |
0,80 |
0,71 |
|
|
Quick ratio |
(r58+r48) / (r102+r116+r117) |
0,27 |
0,32 |
0,34 |
0,32 |
|
|
Cash ratio |
r58 / (r102+r116+r117) |
0,02 |
0,03 |
0,01 |
0,02 |
|
|
Debt ratio I (in %) |
(1-r68/r67) * 100 |
130,56 |
100,82 |
94,10 |
93,36 |
|
|
Debt ratio II (in %) |
r85/r67 * 100 |
130,56 |
100,82 |
88,52 |
93,36 |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.21 |
|
|
1 |
Rs.97.80 |
|
Euro |
1 |
Rs.77.48 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.